Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 18 | 2015 | 117 | 1.840 |
Why?
|
Survivors | 15 | 2020 | 1031 | 1.080 |
Why?
|
Quality of Life | 8 | 2024 | 4532 | 0.860 |
Why?
|
Spirituality | 2 | 2019 | 129 | 0.790 |
Why?
|
Standard of Care | 1 | 2019 | 243 | 0.620 |
Why?
|
Neoplasms | 9 | 2024 | 15193 | 0.600 |
Why?
|
Imipramine | 3 | 2008 | 29 | 0.590 |
Why?
|
Stress Disorders, Traumatic, Acute | 3 | 2015 | 6 | 0.550 |
Why?
|
Limb Salvage | 3 | 2013 | 162 | 0.530 |
Why?
|
Bereavement | 1 | 2012 | 27 | 0.410 |
Why?
|
Fluoxetine | 2 | 2008 | 43 | 0.400 |
Why?
|
Professional-Family Relations | 1 | 2012 | 134 | 0.380 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2010 | 5 | 0.370 |
Why?
|
Health Resources | 2 | 2024 | 168 | 0.370 |
Why?
|
Consumer Behavior | 1 | 2010 | 46 | 0.360 |
Why?
|
Palliative Care | 2 | 2012 | 2037 | 0.350 |
Why?
|
Osteosarcoma | 3 | 2013 | 929 | 0.340 |
Why?
|
Child Health Services | 1 | 2010 | 82 | 0.340 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2008 | 32 | 0.330 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2020 | 604 | 0.310 |
Why?
|
Parents | 2 | 2012 | 998 | 0.310 |
Why?
|
Surveys and Questionnaires | 8 | 2013 | 5687 | 0.300 |
Why?
|
Terminal Care | 1 | 2012 | 447 | 0.290 |
Why?
|
Self Concept | 3 | 2013 | 211 | 0.280 |
Why?
|
Medical Oncology | 4 | 2019 | 1423 | 0.270 |
Why?
|
Fatigue | 1 | 2012 | 1239 | 0.260 |
Why?
|
Child | 21 | 2020 | 29154 | 0.260 |
Why?
|
Pain Management | 2 | 2015 | 668 | 0.240 |
Why?
|
Bone Neoplasms | 3 | 2013 | 2576 | 0.230 |
Why?
|
Adaptation, Psychological | 5 | 2012 | 764 | 0.230 |
Why?
|
Workplace | 1 | 2024 | 76 | 0.230 |
Why?
|
Stress, Psychological | 3 | 2024 | 1000 | 0.220 |
Why?
|
Fentanyl | 1 | 2003 | 148 | 0.210 |
Why?
|
Employment | 3 | 2019 | 129 | 0.210 |
Why?
|
Morphine | 1 | 2003 | 308 | 0.200 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2000 | 35 | 0.180 |
Why?
|
Social Support | 3 | 2012 | 560 | 0.180 |
Why?
|
Analgesics, Opioid | 2 | 2006 | 1371 | 0.150 |
Why?
|
Adolescent | 20 | 2020 | 31252 | 0.150 |
Why?
|
Young Adult | 9 | 2024 | 21445 | 0.150 |
Why?
|
Health Status | 2 | 2012 | 590 | 0.150 |
Why?
|
Adult | 17 | 2024 | 77950 | 0.140 |
Why?
|
Anxiety | 5 | 2020 | 1179 | 0.140 |
Why?
|
Placebos | 2 | 2008 | 437 | 0.130 |
Why?
|
Humans | 31 | 2024 | 261506 | 0.130 |
Why?
|
Female | 24 | 2024 | 141928 | 0.120 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 4314 | 0.120 |
Why?
|
Cancer Survivors | 1 | 2020 | 650 | 0.120 |
Why?
|
Occupational Health | 1 | 2013 | 95 | 0.110 |
Why?
|
Male | 23 | 2019 | 123000 | 0.100 |
Why?
|
Pediatrics | 2 | 2012 | 1141 | 0.100 |
Why?
|
Social Class | 1 | 2013 | 310 | 0.100 |
Why?
|
Focus Groups | 1 | 2012 | 256 | 0.100 |
Why?
|
Family | 2 | 2007 | 736 | 0.100 |
Why?
|
Attitude to Death | 1 | 2012 | 100 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2008 | 2588 | 0.090 |
Why?
|
Mental Disorders | 2 | 2008 | 862 | 0.090 |
Why?
|
Parent-Child Relations | 1 | 2012 | 257 | 0.090 |
Why?
|
Germany | 1 | 2010 | 111 | 0.090 |
Why?
|
Personality Disorders | 1 | 2012 | 164 | 0.090 |
Why?
|
Mood Disorders | 2 | 2013 | 163 | 0.090 |
Why?
|
Caregivers | 1 | 2015 | 677 | 0.090 |
Why?
|
Interpersonal Relations | 2 | 2008 | 290 | 0.080 |
Why?
|
Body Image | 1 | 2010 | 141 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2011 | 289 | 0.080 |
Why?
|
Child, Preschool | 10 | 2015 | 16273 | 0.080 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2012 | 441 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2008 | 901 | 0.080 |
Why?
|
Social Perception | 1 | 2008 | 76 | 0.080 |
Why?
|
United States | 2 | 2024 | 15433 | 0.080 |
Why?
|
Program Evaluation | 1 | 2010 | 597 | 0.070 |
Why?
|
Antipruritics | 1 | 2006 | 2 | 0.070 |
Why?
|
Depressive Disorder | 1 | 2011 | 557 | 0.070 |
Why?
|
Recovery of Function | 1 | 2010 | 703 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2012 | 2292 | 0.070 |
Why?
|
Patient Care Team | 1 | 2012 | 795 | 0.070 |
Why?
|
Psychotherapy | 1 | 2008 | 247 | 0.070 |
Why?
|
Pruritus | 1 | 2006 | 87 | 0.070 |
Why?
|
Anti-Anxiety Agents | 1 | 2006 | 90 | 0.070 |
Why?
|
Hypoxia, Brain | 1 | 2005 | 31 | 0.070 |
Why?
|
Mental Health | 1 | 2008 | 415 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2010 | 915 | 0.060 |
Why?
|
Suicide | 1 | 2006 | 180 | 0.060 |
Why?
|
Intubation | 1 | 2003 | 40 | 0.060 |
Why?
|
Attitude to Health | 1 | 2007 | 465 | 0.060 |
Why?
|
Bandages | 1 | 2003 | 71 | 0.060 |
Why?
|
Pain Measurement | 2 | 2006 | 953 | 0.060 |
Why?
|
Pain | 2 | 2015 | 1658 | 0.060 |
Why?
|
Phantom Limb | 1 | 2003 | 14 | 0.060 |
Why?
|
Antidepressive Agents | 1 | 2005 | 332 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 3472 | 0.050 |
Why?
|
Practice Patterns, Physicians' | 1 | 2011 | 1303 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2003 | 460 | 0.050 |
Why?
|
Siblings | 1 | 2003 | 285 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2013 | 14889 | 0.050 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 274 | 0.050 |
Why?
|
Injury Severity Score | 2 | 2013 | 237 | 0.050 |
Why?
|
Sex Factors | 3 | 2013 | 2139 | 0.050 |
Why?
|
Prevalence | 3 | 2015 | 3260 | 0.050 |
Why?
|
Administration, Oral | 1 | 2003 | 1544 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2005 | 786 | 0.040 |
Why?
|
Acute Disease | 2 | 2006 | 2422 | 0.040 |
Why?
|
Prospective Studies | 3 | 2008 | 12873 | 0.040 |
Why?
|
Middle Aged | 4 | 2015 | 86204 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2013 | 5542 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2003 | 610 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2010 | 37905 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2008 | 32848 | 0.030 |
Why?
|
Risk Assessment | 1 | 2006 | 6869 | 0.030 |
Why?
|
Social Adjustment | 1 | 2012 | 114 | 0.030 |
Why?
|
Depression | 1 | 2020 | 1715 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 332 | 0.020 |
Why?
|
Body Surface Area | 1 | 2008 | 42 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 524 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2013 | 666 | 0.020 |
Why?
|
Texas | 2 | 2008 | 6311 | 0.020 |
Why?
|
Leisure Activities | 1 | 2006 | 17 | 0.020 |
Why?
|
Personality Assessment | 1 | 2006 | 105 | 0.020 |
Why?
|
Age Factors | 2 | 2008 | 5377 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2011 | 636 | 0.020 |
Why?
|
Age of Onset | 1 | 2008 | 827 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2006 | 6100 | 0.020 |
Why?
|
Family Relations | 1 | 2006 | 88 | 0.020 |
Why?
|
Lower Extremity | 1 | 2009 | 299 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2006 | 425 | 0.020 |
Why?
|
Infant | 3 | 2006 | 13310 | 0.020 |
Why?
|
Comorbidity | 1 | 2012 | 2352 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2008 | 552 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2011 | 899 | 0.020 |
Why?
|
Perception | 1 | 2007 | 350 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2015 | 4320 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2013 | 1350 | 0.020 |
Why?
|
Reoperation | 1 | 2009 | 1382 | 0.020 |
Why?
|
Prognosis | 2 | 2013 | 21713 | 0.020 |
Why?
|
Health Behavior | 1 | 2008 | 603 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2006 | 467 | 0.010 |
Why?
|
Psychometrics | 1 | 2008 | 937 | 0.010 |
Why?
|
Sibling Relations | 1 | 2003 | 13 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 1546 | 0.010 |
Why?
|
Trauma Severity Indices | 1 | 2003 | 98 | 0.010 |
Why?
|
Pilot Projects | 1 | 2008 | 2803 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 2315 | 0.010 |
Why?
|
Analgesics | 1 | 2003 | 390 | 0.010 |
Why?
|
Risk Factors | 2 | 2007 | 17523 | 0.010 |
Why?
|
Aging | 1 | 2006 | 1582 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2006 | 8223 | 0.010 |
Why?
|
Aged | 1 | 2015 | 70117 | 0.010 |
Why?
|